WIM
BIVV

Westside Investment Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Westside Investment Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,005
Closed -$55.4K – 870
2017
Q4 		$55.4K Sell
1,005
-100
-9% -$5.47K 0.03% 270
2017
Q3 		$65K Sell
1,105
-200
-15% -$11.7K 0.04% 248
2017
Q2 		$81.1K Hold
1,305
– – 0.05% 219
2017
Q1 		$70.1K Buy
+1,305
New +$64.3K 0.03% 231

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Westside Investment Management's BIVV Position: Q1 2018 in Review

Westside Investment Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,005 shares — an estimated $55.4K sold.

Westside Investment Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $81.1K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Westside Investment Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Westside Investment Management sold 1,005 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $55.4K.
  • Westside Investment Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Westside Investment Management's Bioverativ Inc. Common Stock position peaked at $81.1K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Westside Investment Management's 13F filing for Q1 2018, filed 16 Apr 2018.